Free Trial

Aberdeen Group plc Has $19.28 Million Stock Holdings in Molina Healthcare, Inc $MOH

Molina Healthcare logo with Medical background

Key Points

  • Aberdeen Group plc decreased its stake in Molina Healthcare, Inc by 13.8% in Q2, owning 64,726 shares valued at approximately $19.28 million after selling 10,400 shares.
  • Several institutional investors, including Price T Rowe Associates Inc., have increased their stakes in Molina Healthcare, indicating strong interest from large investors.
  • Molina Healthcare reported earnings of $5.48 per share for the last quarter, missing estimates slightly, but saw a revenue increase of 15.7% year-over-year, totaling $11.43 billion.
  • Interested in Molina Healthcare? Here are five stocks we like better.

Aberdeen Group plc decreased its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 13.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,726 shares of the company's stock after selling 10,400 shares during the period. Aberdeen Group plc owned 0.12% of Molina Healthcare worth $19,282,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD increased its stake in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock valued at $1,264,214,000 after buying an additional 1,216,903 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in shares of Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company's stock valued at $490,099,000 after buying an additional 117,796 shares during the period. AQR Capital Management LLC increased its stake in shares of Molina Healthcare by 42.7% in the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company's stock valued at $288,125,000 after buying an additional 264,664 shares during the period. Durable Capital Partners LP increased its stake in shares of Molina Healthcare by 13.1% in the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company's stock valued at $178,399,000 after buying an additional 62,899 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Molina Healthcare by 1.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company's stock valued at $153,388,000 after buying an additional 7,021 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Insider Activity at Molina Healthcare

In related news, COO James Woys bought 10,000 shares of the company's stock in a transaction dated Monday, August 4th. The shares were bought at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares of the company's stock, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by corporate insiders.

Molina Healthcare Stock Up 0.2%

Shares of NYSE:MOH opened at $194.44 on Tuesday. The business's 50 day simple moving average is $179.00 and its two-hundred day simple moving average is $247.39. The firm has a market cap of $10.54 billion, a P/E ratio of 9.58 and a beta of 0.55. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $359.97.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm's revenue was up 15.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.86 EPS. As a group, research analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on MOH shares. Sanford C. Bernstein decreased their price target on Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a research note on Friday, September 5th. Mizuho cut their target price on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a research report on Friday, July 11th. Truist Financial restated a "hold" rating and set a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Barclays cut their target price on Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating on the stock in a research report on Thursday, September 4th. Finally, Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $228.18.

Get Our Latest Report on Molina Healthcare

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.